Blue Trust’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
Blue Trust's FLGT Position: Q3 2026 in Review
Blue Trust sold out of Fulgent Genetics (FLGT) in Q3 2026, closing a stake of 63 shares — an estimated $1.29K sold.
Blue Trust first reported a position in FLGT in Q2 2022 and held it in 13 quarters. The position peaked at $33K in Q3 2022. 96 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.
- Blue Trust reported no remaining Fulgent Genetics position as of Q3 2026 after selling out during the quarter.
- Blue Trust sold 63 Fulgent Genetics shares in Q3 2026, an estimated $1.29K.
- Blue Trust first reported a position in Fulgent Genetics in Q2 2022 and held it in 13 quarters.
- Blue Trust's Fulgent Genetics position peaked at $33K in Q3 2022.
- 96 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.